Apyx Medical Corporation (APYX) Reports a Net Loss for Q4 FY25

[ad_1]

Apyx Medical Corporation (APYX), an energy technology company that designs and manufactures electrosurgical equipment and medical devices, reported fourth quarter 2025 financial results.

Apyx Medical Corporation (APYX) posted a Q4 2025 loss of $0.03 per share. The company generated $19.2M in revenue for the quarter. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM), serving customers in the United States and internationally.

A detailed analysis of Apyx Medical Corporation’s quarter follows shortly on AlphaStreet.

This article was generated using AlphaStreet’s proprietary financial analysis technology and reviewed by our editorial team.

[ad_2]

Source link

Leave a Reply